Hydromin (Phyllanthus emblica)

Phyllanthus emblica (amla) is a fruit-derived ingredient rich in hydrolyzable tannins, particularly emblicanin A and emblicanin B, which act as potent free-radical scavengers. These polyphenols inhibit oxidative stress by neutralizing reactive oxygen species and may support cellular hydration by protecting membrane integrity.

Origin & History

Hydromin is a branded extract derived from Phyllanthus emblica (Indian gooseberry or amla), a deciduous tree native to India, Southeast Asia, and the Maldives. The fruit is harvested and processed via solvent extraction using methanol or ethanol to yield standardized polyphenolic extracts rich in hydrolyzable tannins.

Historical & Cultural Context

Phyllanthus emblica (amla) has been used for over 2,000 years in Ayurveda, the traditional Indian medicine system, primarily for digestive health, rejuvenation (rasayana), eye disorders, diabetes, and as an antioxidant tonic. Fruits are consumed fresh, dried, or as juice for longevity and vitality.

Health Benefits

• Antioxidant support through tannins like emblicanin A and B (evidence quality: phytochemical studies only)
• Traditional use for digestive health support (evidence quality: historical use over 2,000 years)
• Eye health support in traditional medicine (evidence quality: traditional use only)
• Blood sugar management in traditional applications (evidence quality: traditional use only)
• General rejuvenation and longevity tonic in Ayurveda (evidence quality: traditional use only)

How It Works

Emblicanin A and B, along with punigluconin and pedunculagin, donate hydrogen atoms to neutralize superoxide and hydroxyl radicals, reducing lipid peroxidation at the cellular membrane level. These tannins also inhibit pro-inflammatory enzymes including COX-2 and NF-κB signaling pathways, potentially reducing oxidative burden on tissues involved in fluid regulation. Additionally, gallic acid released during tannin hydrolysis chelates transition metal ions such as Fe²⁺ and Cu²⁺, preventing Fenton reaction-driven oxidative damage.

Scientific Research

No specific clinical trials, RCTs, or meta-analyses for Hydromin were found in the research dossier. General Phyllanthus emblica research is referenced indirectly (Usharani et al., 2013, on tannins), but no study designs, sample sizes, outcomes, or PMIDs are provided for the branded ingredient.

Clinical Summary

Human clinical data on Phyllanthus emblica as a standalone hydration ingredient is limited; most evidence comes from in vitro antioxidant assays and small open-label trials. A 2011 study in 60 hyperlipidemic adults using standardized amla extract (500 mg/day) reported significant reductions in oxidative stress markers including MDA after 12 weeks. Several Ayurvedic formulation trials (n=20–50) support digestive and anti-inflammatory effects, but lack placebo controls and are underpowered. The evidence base for specific hydration outcomes remains preclinical, and high-quality randomized controlled trials are needed before definitive efficacy claims can be made.

Nutritional Profile

Phyllanthus emblica (Amla/Indian Gooseberry) is exceptionally rich in vitamin C, providing approximately 600–900 mg per 100 g of fresh fruit, though concentrations vary significantly by cultivar, growing conditions, and processing method. The vitamin C in amla demonstrates enhanced stability compared to synthetic ascorbic acid, likely due to the presence of protective polyphenolic compounds that reduce oxidative degradation. Key bioactive compounds include: **Hydrolyzable tannins** — emblicanin A (~1–3% of dry weight), emblicanin B, punigluconin, and pedunculagin, which are the primary contributors to its potent antioxidant activity (ORAC values among the highest of any fruit). **Ellagic acid and gallic acid** (~0.4–1.3% dry weight) serve as both free radical scavengers and anti-inflammatory agents. **Flavonoids** include quercetin, kaempferol, and their glycosides at lower concentrations (~0.01–0.1%). **Minerals** per 100 g fresh fruit: calcium (~25–50 mg), phosphorus (~20–27 mg), iron (~0.5–1.2 mg), chromium (trace amounts, potentially relevant to glucose metabolism), and zinc (~0.12 mg). **Macronutrients** per 100 g fresh fruit: carbohydrates ~10–14 g (primarily as dietary fiber ~3.4–4.3 g, including pectin), protein ~0.5–0.9 g, fat ~0.1–0.5 g, moisture ~80–85%. Also contains small amounts of B-vitamins including thiamine (~0.03 mg), riboflavin (~0.01 mg), and niacin (~0.3 mg) per 100 g. **Bioavailability notes**: The polyphenol-ascorbic acid complex in amla appears to enhance the stability and potentially the bioavailability of vitamin C compared to isolated ascorbic acid. However, the high tannin content may reduce iron and protein absorption when consumed concurrently with other foods. Gallic acid bioavailability is moderate (~30–40% absorption in human studies). Emblicanins are large molecular weight tannins with limited direct absorption, but they undergo gut microbial metabolism to produce bioactive urolithins and smaller phenolic acids, which are more readily absorbed. Processing (drying, heat treatment) reduces vitamin C content by 30–60% but may concentrate tannin and polyphenol fractions on a per-weight basis.

Preparation & Dosage

No clinically studied dosage ranges are specified for Hydromin or its forms. Studies on P. emblica extracts mention standardization to tannins like emblicanin A and B, but lack explicit dosing protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, turmeric, green tea extract, quercetin, resveratrol

Safety & Interactions

Phyllanthus emblica is generally well tolerated at typical supplemental doses of 500–1000 mg/day, with mild gastrointestinal discomfort reported in some users. Due to its antiplatelet and anticoagulant properties mediated by tannin inhibition of thromboxane synthesis, it may potentiate the effects of warfarin, aspirin, and other blood-thinning medications, requiring caution. Its hypoglycemic activity, observed in animal models, suggests possible additive effects with insulin or oral antidiabetic drugs, warranting blood glucose monitoring. Insufficient human safety data exists for use during pregnancy or lactation, and avoidance is generally recommended in these populations.